Abstract
Molluscum contagiosum is a common, often persistent viral skin infection affecting children, and spread by infected individuals or objects. No molluscum management guidelines exist and only two FDA treatments have been approved in the last year, thus placing pediatricians in a clinical conundrum if molluscum treatment is warranted. When MC is particularly bothersome or persistent, parental anxiety may influence treatment. In-depth interviews with 25 pediatricians provided insight into the current MC treatment landscape and drivers of therapeutic intervention. This study reveals the important influence parental anxiety, patient characteristics, and parental involvement have on pediatrician’s molluscum management and treatment intervention practices. Professional society endorsed molluscum management guidelines and the use of safe and efficacious FDA-approved therapies would fill therapeutic gaps.
Publisher
Peertechz Publications Private Limited
Reference9 articles.
1. 1. Chen X, Anstey AV, Bugert JJ. Molluscum contagiosum virus infection. Lancet Infect Dis. 2013 Oct;13(10):877-88. doi: 10.1016/S1473-3099(13)70109-9. Epub 2013 Aug 21. PMID: 23972567.
2. 2. Committee on Infectious Diseases. American Academy of Pediatrics. Red Book: 2021-2024. Report of the Committee on Infectious Diseases. 32nd ed. American Academy of Pediatrics; 2021.
3. 3. American Academy of Dermatology. Molluscum contagiosum: an overview. Accessed December 16, 2022. https://www.aad.org/public/diseases/a-z/molluscum-contagiosum-overview
4. 4. van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017 May 17;5(5):CD004767. doi: 10.1002/14651858.CD004767.pub4. PMID: 28513067; PMCID: PMC6481355.
5. 5. Verrica Pharmaceuticals Inc. YCANTH™ (cantharidin) topical solution. 2023. https://ycanth.com/wp-content/uploads/2023/07/USPI_FPI-0003_YCANTH.pdf. Accessed 8 September 2023